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Abstract
Background: Stanniocalcin 2 (STC2) is a secreted protein activated by (PKR)-like Endoplasmic Reticulum Kinase
(PERK) signalling under conditions of ER stress in vitro. Over-expression of STC2 in mice leads to a growth-restricted
phenotype; however, the physiological function for STC2 has remained elusive. Given the relationship of STC2 to
PERK signalling, the objective of this study was to examine the role of STC2 in PERK signalling in vivo.
Results: Since PERK signalling has both physiological and pathological roles in the pancreas, STC2 expression was
assessed in mouse pancreata before and after induction of injury using a cerulein-induced pancreatitis (CIP) model.
Increased Stc2 expression was identified within four hours of initiating pancreatic injury and correlated to increased
activation of PERK signalling. To determine the effect of STC2 over-expression on PERK, mice systemically
expressing human STC2 (STC2
Tg) were examined. STC2
Tg pancreatic tissue exhibited normal pancreatic morphology,
but altered activation of PERK signalling, including increases in Activating Transcription Factor (ATF) 4 accumulation
and autophagy. Upon induction of pancreatic injury, STC2
Tg mice exhibited limited increases in circulating amylase
levels and increased maintenance of cellular junctions.
Conclusions: This study links STC2 to the pathological activation of PERK in vivo, and suggests involvement of
STC2 in responding to pancreatic acinar cell injury.
Background
The stanniocalcin (STC) family of secreted glycoproteins
consists of two members - STC1 and STC2 - that have
35% conserved identity and conservation of exon/intron
boundaries, indicating that they are paralogs [1]. STC
was first discovered in fish and shown to be involved in
calcium homeostasis through effects on calcium influx
[2,3]. Although terrestrial mammals rarely experience
hypercalcemia, alterations in subcellular compartmenta-
lization of Ca
2+ are found under pathological conditions
such as the accumulation of improperly folded proteins.
STC2 expression is upregulated upon induction of
hypoxic or endoplasmic reticulum (ER) stress in N2a
neuroblastoma cells [4]. This increase in Stc2 expression
was reliant on the concomitant increase of Activating
Transcription Factor (ATF4) [5], a protein integral to
(PKR)-like endoplasmic reticulum kinase (PERK) signal-
ling, which is part of the unfolded protein response
(UPR). To date, no relationship between PERK signalling
and STC2 activation has been identified in vivo.
The UPR is activated when ER homeostasis is dis-
rupted. Alterations to proper functioning of ER machin-
ery arise when protein load exceeds folding capacity,
such as when luminal ER Ca
2+ concentrations are per-
turbed. The UPR consists of three signalling pathways
that are individually transduced by ATF6, inositol-
requiring enzyme 1 (IRE1) or PERK [6,7]. Each transdu-
cer is maintained in a repressed state by binding of the
ER chaperone protein glucose regulated protein 78
(GRP78/BiP) [6,7]. When unfolded proteins accumulate,
they bind to GRP78/BiP resulting in its release from the
UPR transducers [8,9]. In the case of PERK, dissociation
of GRP78/BiP leads to its homodimerization and autoac-
tivation [10]. Activation of PERK results in phosphoryla-
tion of eukaryotic translation initiation factor 2a (eIF2a)
[11], limiting its ability to contribute to the protein
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any medium, provided the original work is properly cited.translational complex, thereby inhibiting global protein
translation and alleviatingt h ep r o t e i nl o a do nt h ec e l l
[12]. Phosphorylation of eIF2a also selectively upregu-
lates translation of mRNAs from short upstream open
reading frames [13]. The predominant target mRNA for
peIF2a is Atf4, which subsequently increases the expres-
sion of the transcriptional repressor Atf3,a n dgrowth
arrest and DNA damage-inducible (Gadd) 34 [14,15].
GADD34 (alternatively known as Myd116; myeloid dif-
ferentiation, primary response gene 116,o rPpp1r15a;
protein phosphatase 1, regulatory [inhibitor] subunit
15A) negatively regulates PERK signalling by combining
with protein phosphatase 1 to dephosphorylate eIF2a,
thereby restoring general translation [16,17].
PERK is expressed in the exocrine and endocrine pan-
creas under normal conditions [11,18] and Perk
-/- mice
experience deterioration of glycemic control and exo-
crine insufficiency over time [19]. Exocrine specific dele-
tion of PERK revealed cellular disorganization and
degranulation, increased serum amylase levels and
increased cell death [20]. Our laboratory identified rapid
activation of PERK signalling following induction of
pancreatitis by supramaximal secretagogue stimulation
and correlated decreased activation of the pathway in
mice that exhibit increased sensitivity to pancreatic
injury [21]. Together, these observations indicate that
PERK signalling has important roles in both the physiol-
ogy and pathology of the exocrine pancreas.
Given the relationship between PERK and STC2
in vitro, the objectives of this study were to (1) deter-
mine if a similar relationship exists in the exocrine pan-
creas and (2) gain insight into a role for STC2 as part of
the UPR. Our results revealed a correlation of Stc2
expression with PERK signalling in vivo only after initi-
ating pancreatic injury. Transgenic over-expression of
STC2 in mice (STC2
Tg)[ 2 2 ]r e s u l t e di na l t e r e dP E R K
signalling and decreased signs of acinar cell damage
associated with cerulein-induced pancreatitis (CIP).
These observations suggest that STC2 is linked to PERK
signalling in acinar cells and may have a role in limiting
damage during pancreatic injury.
Results
To determine if PERK signalling is active in pancreatic
tissue, we performed IF with an antibody that recognizes
only the phosphorylated form of PERK (pPERK). The
accumulation of pPERK was restricted to a tight apical
portion of the acinar cells (Figure 1A, green, arrows)
typical of where Ca
2+ is released during the process of
regulated exocytosis. RT-PCR revealed no expression of
Stc2 in control pancreata (Figure 1C). Similar results
were obtained in control pancreata for Atf3,a n o t h e r
downstream target of PERK signalling suggesting that
PERK activation under resting conditions does not
activate all downstream mediators of PERK signalling.
Our laboratory has shown that activation of PERK signal-
ling increases during pancreatic injury [21]. To determine
if the pathological activation of PERK leads to increased
STC2 expression, pancreatic injury was initiated by ceru-
lein-induced pancreatitis (CIP). Interestingly, CIP treat-
ment led to a change in pPERK localization within four
hours, with active PERK exhibiting a more diffuse and
basally-restricted pattern of accumulation (Figure 1B,
green, arrow), similar to the changes observed for acinar
cell exocytosis under these conditions [23]. This change
in localization was accompanied by increased Stc2 and
Atf3 mRNA accumulation (Figure 1C). Increased Stc2
expression was confirmed by Northern blot analysis four
hours after induction of pancreatitis (Figure 1D, saline
WT vs. CIP WT). While we were unable to detect STC2
protein by IF analysis (data not shown), increased
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Figure 1 STC2 accumulation increases in pancreatic tissue
following induction of pancreatic injury. (A, B)
Immunofluorescence (IF) for pPERK (green) before (A) and 4 hours
after (B) initiation of CIP. pPERK (arrowhead) localizes to the apical
end of acinar cells under physiological conditions and more basally
during CIP. Magnification bar = 13 μM. DAPI was used to counter
stain nuclei. (C) RT-PCR of whole pancreatic RNA extracts from
saline (S) and cerulein (C) treated mice showed increased
accumulation of Stc2 and Atf3 mRNA after initiation of CIP in
pancreatic tissue. Amplification of Amylase (Amy) was used as a
positive control for RT reactions. (D) Northern blot analysis revealed
elevated Stc2 mRNA four hours after initial cerulein (CIP) or saline (S)
injection. No increases in Stc2 were observed in Mist1
-/- (M-/-)
pancreatic tissue under similar conditions. (E, F) IF for ATF3
expression revealed limited accumulation before CIP (E) and acinar-
specific expression afterwards (F). Magnification bar = 63 μM. I =
islet.
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cells in CIP-treated pancreatic tissue (Figure 1E, F; I =
islet). To support the link between elevated Stc2 levels
and injury-associated PERK activation, we examined the
expression of Stc2 in Mist1
-/- mice, which exhibit mini-
mal activation of PERK during injury. Mist1 is a tran-
scription factor required for terminal differentiation of
pancreatic acinar cells, and its absence in exocrine tissue
results in improper activation of UPR components both
normally and during injury [21]. In sharp contrast to wild
type mice, Stc2 mRNA was virtually undetectable upon
CIP treatment of Mist1
-/- mice (Figure 1D; Saline Mist1
-/-
vs. CIP Mist1
-/-).
These findings suggest that STC2 is co-induced with
PERK in acinar cells only after injury and may protect
the pancreas in response to CIP. To determine if STC2
could alter the acinar cell response to pancreatic injury,
we examined a mouse model in which STC2 is constitu-
tively expressed (STC2
Tg; [22]). IHC confirmed increased
accumulation of STC2 in STC2
Tg pancreata compared to
wild type (WT) tissue, with STC2 accumulation in islets
and exocrine tissue (Figure 2A, B). H&E histology
(Figure 2C, D) indicated that morphology was not overtly
altered in STC2
Tg pancreatic tissue. IF staining for
pancreatic differentiation markers MIST1 (exocrine,
Figure 2E, F) and PDX1 (endocrine, Figure 2G, H) showed
similar spatial localization and GLUT-2 accumulation was
localized to the cell membrane of endocrine cells in both
genotypes (Figure 2I, J). Western blot analysis confirmed
equivalent levels of these markers, as well as amylase,
between WT and STC2
Tg tissue (Figure 2K).
We next examined PERK signalling in STC2
Tg pan-
creatic tissue. PERK activation results in phosphoryla-
tion of eIF2a and translation of ATF4 [24,25]. ATF4 is
required for expression of Gadd34, Atf3 and Stc2
[5,14,16]. Western blot analysis of WT and STC2
Tg pan-
creatic tissue revealed decreased phosphorylation of
both PERK and eIF2a (Figure 3A, B; n = 4 animals; p <
0.01) in STC2
Tg tissue. Surprisingly, ATF4 accumulated
to higher levels in the STC2
Tg pancreas, suggesting dys-
regulation of PERK signalling. We next examined XBP1,
another mediator of the UPR that is outside of the
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Figure 2 Overall morphology and differentiation does not appear to be affected in STC2
Tgmice. (A, B) IHC for STC2 in WT (A) and STC2
Tg
(B) pancreatic islets shows that STC2 accumulates in both acinar (*) and islet (I) tissue only in the STC2
Tg mice. Magnification bar = 27 μm.
Tissue was counterstained with hematoxylin to reveal tissue morphology. (C, D) Hematoxylin and eosin staining comparing general histology of
pancreatic tissue in WT (C) or STC2
Tg (D) pancreata. Magnification bar = 60 μM; I - islet. IF analysis for MIST1 (E, F), PDX1 (G, H) or GLUT2 (I, J)i n
WT (E, G, I)o rSTC2
Tg (F, H, J) pancreata. Magnification bar = 54 μm. (K) Representative Western blot analysis for pancreatic differentiation
markers amylase, MIST1, PDX1 and GLUT2.
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Page 3 of 11PERK signalling pathway. Xbp1 mRNA is targeted by
the endonuclease activity of IRE1 leading to production
of an active, spliced (s) form of XBP1 [26]. Western blot
analysis revealed a consistent decreased in sXBP1 accu-
mulation in STC2
Tg mice indicating that elevated STC2
levels may also affect the other UPR pathways.
To understand why activation of PERK and eIF2a
appear reduced in STC2
Tg tissue, we examined regulators
of these two proteins. The phosphorylation of eIF2a is
reversed by GADD34 through its interaction with protein
phosphatase 1 (PP1) and recent evidence indicates that
calcineurin binds PERK and stimulates its autophosphor-
ylation [27]. In STC2
Tg pancreatic tissue, the levels of
GADD34 protein were significantly higher than wild type
tissue (Figure 3C). Conversely, STC2
Tg calcineurin levels
were considerably lower than WT counterparts. No
changes in the ER resident protein calregulin were
observed between genotypes (Figure 3C). Based on these
results, it appears that over-expression of STC2 affected
expression of mediators and feedback mechanisms in
PERK signalling.
Alterations to PERK/ATF4 signalling should have an
effect on cell autophagy, a long-term response to ER
stress, which is regulated by ATF4 during hypoxia [28].
Western blot analysis followed by densitometry revealed
a significant increase in the cleaved form of the autop-
hagy marker myosin associated protein 1 light chain 3
(LC3) in STC2
Tg pancreatic tissue (Figure 4A, B; n = 4
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Figure 3 Systemic over-expression of STC2 (STC2
Tg)a l t e r st h e
PERK signalling pathway in pancreatic tissue. (A) Representative
Western blot analysis for mediators of PERK signalling: pPERK,
peIF2a, total (t) eIF2a, ATF4 and sXBP1 in wild type (WT) and STC2
Tg
(Tg), revealed decreased levels of pPERK, peIF2a and sXBP1, and
increased amounts of ATF4 in STC2
Tg mice. (B) Densitometry
revealed that the ratio of peIF2a to total eIF2a is decreased in
STC2
Tg extracts relative to WT tissue (n = 3 animals; *p < 0.05). (C)
Similar western blot analysis revealed increased accumulation of
GADD34 and decreased accumulation of calcineurin in STC2
Tg
pancreatic protein extracts. No difference in calregulin accumulation
was observed. Molecular weights (kDa) are provided.
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Figure 4 STC2
Tgacinar cells have increased autophagy. (A)
Representative Western blot analysis for LC3 I and LC3 II
accumulation in wild type (WT) and STC2
Tg (Tg)pancreatic extracts
revealed increased accumulation of cleaved LC3 II which was (B)
quantified by densitometry (n = 3 animals; *p < 0.05). IF for LC3
cellular accumulations in (C) WT and (D) STC2
Tg pancreatic sections
showed increased autophagic vesicles (arrowhead) in STC2
Tg
pancreatic tissue. Magnification bar = 10 μm.
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Page 4 of 11animals p < 0.01) consistent with increased accumula-
tion of ATF4 in STC2
Tg mice. IF analysis corroborated
increased autophagy as punctate LC3 staining is notably
increased in STC2
Tg exocrine tissue (Figure 4D) when
compared to WT tissue (Figure 4C).
The alterations in PERK signalling and cell autophagy
suggested that STC2
Tg mice should have altered sensitiv-
ity to pancreatic injury. Four hours after the induction
of pancreatitis, we compared circulating serum amylase
levels and tissue edema between WT and STC2
Tg mice
(Figure 5). While serum amylase levels were moderately
higher in saline-treated STC2
Tg mice, the proportional
increase in serum amylase levels following CIP was sig-
nificantly lower in STC2
Tg mice when compared to WT
mice, indicative of decreased sensitivity to pancreatic
insult (Figure 5A; n = 4 animals; p < 0.05). However, no
difference was observed in tissue edema after CIP
between genotypes (Figure 5B). We next examined the
effects of pancreatic injury at the cellular level by exam-
ining enzyme activation and cell structures. Western
blot analysis of procarboxypeptidase (CPA) activation
revealed reduced levels of active CPA in CIP STC2
Tg
pancreatic tissue when compared to WT cerulein-trea-
ted tissue (Figure 5C, D). Interestingly, analysis of cell
junction proteins showed continued expression in
STC2
Tg tissue following CIP that was not evident in WT
tissue. In WT acinar cells, the expression of b-catenin
decreased to negligible levels, indicative of a loss in
adherens junctions between acinar cells as expected
(Figure 5E, F). However, b-catenin remained readily
detectable in STC2
Tg pancreatic tissue after induction of
CIP (Figure 5G, H). Similarly, punctate connexin32
(Cx32) accumulation was lost in WT (Figure 5I, J) but
not in STC2
Tg acini (Figure 5K, L) suggesting a greater
disruption in gap junction complexes in WT acinar
cells. Western blot analysis corroborated IF data with
CIP leading to a more dramatic loss of b-catenin and
Cx32 accumulation in WT extracts compared to STC2
Tg
extracts after four hours (Figure 5M) indicating that
intercellular complexes were protected in STC2
Tg mice,
suggestive of reduced cellular damage. Combined, these
findings suggest that acinar cell integrity is maintained
to a higher degree when acini are exposed to higher
than normal levels of STC2.
As a final marker for CIP severity, we assessed the
amount of acinar cell necrosis and apoptosis within the
two genotypes. The ratio of necrosis to apoptosis corre-
lates to CIP severity [29]. Visualization of apoptosis
using TUNEL staining revealed increased apoptosis in
both WT (Figure 6A, B; arrowheads) and STC2
Tg
(Figure 6C, D; arrowheads) pancreatic tissue after induc-
tion of pancreatitis. Quantification of TUNEL positive
cells revealed slight decreases in acinar cell apoptosis in
STC2
Tg tissue (Figure 6E). We next examined necrosis
through IF for High mobility group protein b1
(HMGB1), a protein that interacts with DNA, but upon
necrotic stimulus, is released from the nucleus and the
cell to participate in inflammatory responses [30,31].
Cytoplasmic staining of HMGB1 is routinely used as an
indicator of cell necrosis. HMGB1 is localized to the
nucleus in both WT (Figure 6F) and STC2
Tg (Figure 6H)
saline treated tissue. After induction of pancreatitis, punc-
tate, cytoplasmic HMBG1 staining was observed in
distinct patches of cells only in WT tissue (Figure 6G).
All STC2
Tg tissue analysed was devoid of punctate cyto-
plasmic HMGB1 staining (Figure 6I). This analysis reveals
that the levels of both apoptosis and necrosis are
decreased in STC2
Tg tissue, indicative of less tissue
damage after CIP.
Discussion
STC2 is a secreted protein that, when expressed to high
levels in mice, has profound effects leading to growth
restriction [22]. However, ablation of Stc2 in mice
results in limited phenotypic alterations suggesting that
STC2 functions may fall outside normal physiology [32].
In support of such a hypothesis, in vitro analysis has
identified increased Stc2 accumulation following treat-
ment with thapsigargin or tunicamycin, agents that acti-
vate ER stress pathways [5]. STC2 is also up-regulated
in response to hypoxic insult and is expressed to higher
levels in many tumor-derived cell lines [4,33]. This sug-
gests that STC2 may be involved in responding to exter-
nal challenges that activate cell stress pathways. In this
study, we have identified increased Stc2 accumulation
within four hours of inducing pancreatic injury that cor-
related with activation of the PERK signalling. Impor-
tantly, forced expression of STC2 in mice altered PERK
signalling and reduced cellular damage in response to
pancreatic injury. These results suggest a role for STC2
responding to and mediating the effects of cell stress in
pancreatic tissue.
Studies assessing the expression of Stc2 have revealed
a limited expression pattern in adult tissues. In the
human pancreas, Stc2 is specifically expressed in alpha
cells of the islets of Langerhans and not in acinar tissue
[1]. Our mRNA analysis revealed murine pancreatic
expression of Stc2 only after induction of pancreatitis by
supramaximal secretagogue stimulation. Unfortunately,
IHC on CIP-treated tissue sections did not detect STC2
protein (data not shown) indicating that STC2 may be
expressed at lower than detectable levels or that it is
rapidly secreted into the circulation. While we have not
definitively identified acini as the origin of Stc2 expres-
sion, Atf3, a downstream mediator of PERK signalling,
accumulated only in acinar cells during CIP, suggesting
that CIP treatment leads to a cell autonomous activation
of Stc2. As observed in HEK293 and N2a neuroblastoma
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Figure 5 STC2 over-expression reduces severity of acinar cell damage during cerulein-induced pancreatic injury. (A) Analysis of serum
amylase levels four hours into CIP treatment show that serum amylase levels rise approximately 3 fold in WT mice when compared to saline (￿)
whereas the increase in STC2
Tg mice is significantly lower at 2-fold (■; * p < 0.01). (B) Tissue edema analysis revealed significant increases for
both WT and STC2
Tg tissue 4 hours into CIP (black bars) when compared to saline controls (white bars; n = 4 animals). No difference between
genotypes was observed. (C) Representative Western blot for procarboxypeptidase (47 kDa) and carboxypeptidase (CPA; 33 kDa) or trypsinogen
four hours after initial saline (Sal.) or cerulein (CIP) injections showed decreased accumulation of activate CPA in STC2
Tg mice four hours into CIP.
Trypsinogen levels do not differ between genotypes. (D) Quantification by densitometry (graph) comparing the ratio of cleaved (active; 33 kDa)
to total CPA revealed a significant increase in WT tissue and, to a significantly lower extent, in STC2
Tg tissue (n = 4 animals, letters represent
statistically different values; p < 0.05). IF analysis for b-catenin (E-H) or Cx32 (I-L) in wild type (WT) or STC2
Tg (Tg) mice four hours after initial
injection of saline (E, G, I, K) or cerulein (F, H, J, L) showing decreased accumulation only in WT tissue during CIP. (M) Representative Western
blot analysis on pancreatic protein extracts 4 hours after initial saline or cerulein (CIP) injection confirm decreased b-catenin and Cx32
accumulation only in WT-CIP treated tissue (n = 4).
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with activation of PERK signalling in response to injury
[5]. Induction of Stc2 mRNA levels was not observed
after CIP in Mist1
-/- mice, which do not activate PERK
or ATF3, and experience increased severity of CIP [21].
These findings support the activation of Stc2 as a pro-
tective mechanism, potentially as a mediator of the UPR.
While previous studies have correlated increased
expression of STC2 as part of the UPR, the effects of
STC2 on PERK signalling have not been examined. We
have now shown that systemically high levels of STC2
reduce PERK activation. STC2
Tg mice showed decreased
phosphorylation of PERK and eIF2a in pancreatic tissue
suggesting that continued exposure to STC2 may lead
to activation of negative feedback mechanisms. Since no
change in total eIF2a is observed, this difference is
peIF2a is specific to the phosphorylation event and not
decreased eIF2a accumulation. While we showed a
decrease in pPERK, total PERK levels were not assessed
and this could account for possible differences in activa-
tion of the pathways as well.
We have identified at least two effectors of the PERK
signalling pathway that were changed in STC2
Tg mice.
First, GADD34, which combines with protein phospha-
tase 1 to reduce eIF2a phosphorylation [17], accumu-
lated to higher levels. Second, we observed significantly
decreased accumulation of calcineurin, which stimulates
PERK autophosphorylation, thereby increasing activity
[27]. Whether these changes are reflective of a direct
role for STC2 in their regulation or a response to other
events caused by over exposure to STC2 is unclear.
However, the altered expression of these factors suggests
ar o l ef o rS T C 2i nr e g u l a t i n gC a
2+ homeostasis since
both calcineurin and PERK are affected by altered Ca
2+
sequestration in the ER. These data suggest that consti-
tutive exposure to STC2 results in depression of the
activity of key factors regulating the UPR.
In light of decreased PERK and eIF2a activation, it was
surprising that increased accumulation of ATF4 was
observed in the pancreas of STC2
Tg mice. Phosphorylation
of eIF2a is known to stimulate translation of Atf4 mRNA,
leading to increased ATF4 protein accumulation. How-
ever, increased ATF4 expression, and the subsequent
increase in GADD34 could be mediated by increased sta-
bility of the ATF4 protein. Recent studies have shown that
ATF4 is stabilized by interaction with p300 through inhi-
bition of ubiquitination [34], and that association with
p300/CBP enhances ATF4 transcriptional ability [34,35]. It
is possible that in STC2
Tg mice, stabilization of ATF4 is
enhanced regardless of decreased phosphorylation of
eIF2a, accounting for its increased expression. Although
there is little known about non-peIF2a related transcrip-
tional activation of ATF4, increased transcriptional activa-
tion by a yet to be identified factor cannot be ruled out.
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Figure 6 Cell death is decreased during CIP in STC2
Tgtissue.
TUNEL analysis revealed apoptosis (arrowheads) during CIP (B, D)
but not saline injections (A, C)i nW T( A, B) and STC2
Tg (C, D)
pancreata. Magnification bar = 45 μM. (E) Quantification of TUNEL
positive cells in WT and STC2
Tg tissue (n = 4 animals; letters indicate
significant differences). (F-I) HMGB1 IF to identify necrosis revealed
nuclear localization in saline conditions for WT (F; n = 3 animals)
and STC2
Tg (H; n = 3 animals) tissue. After induction of pancreatitis,
patches of cells with cytoplasmic, punctate HMGB1staining,
indicative of necrosis, were observed in WT tissue (G; n = 4 animals)
but not in STC2
Tg tissue (I; n = 4 animals). Magnification bar = 34
μM
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Page 7 of 11Figure 7 summarizes a potential role for STC2 in the
UPR, where over-expression of STC2 negatively affects
calcineurin expression, (Figure 7, dotted line), which
would lead to inhibition of calcineurin-dependent phos-
phorylation of PERK. Decreased phosphorylation of
PERK results in decreased phosphorylation of eIF2a,a s
observed in STC2
Tg pancreatic tissue. Although the
increased expression of ATF4 in STC2
Tg tissue is not
intuitive considering the phosphorylation of both PERK
and eIF2a, it reveals a potential role for STC2 in ATF4
regulation (Figure 7, dotted arrow). This increase in
ATF4 expression leads to increased GADD34 expres-
sion, which acts as a negative feedback mechanism to
contribute to decreased phosphorylation of eIF2a [16].
As would be expected from increased ATF4 expres-
sion, STC2
Tg mice also exhibited an increased level of
autophagy, a downstream consequence of elevated
ATF4 levels. Autophagy is important for maintenance of
cellular homeostasis through balancing synthesis and
degradation or recycling of cellular components. Inde-
pendent studies have indicated that either phosphoryla-
tion of eIF2a or expression of ATF4 is required for
induction of autophagy in vitro [28,36,37]. The increased
expression of ATF4 in STC2
Tg pancreatic tissue may be
the cause of increased autophagy. Interestingly, we did
not observe increased acinar cell apoptosis (data not
shown), which is another downstream result of
increased UPR. Therefore, it appears that only certain
parts of the UPR have been activated in STC2
Tg mice.
Whether STC2 is protective in nature is still unclear
since studies have shown it has both protective [38] and
detrimental roles [4,33] in cancer progression in vitro.
Our results suggest a protective advantage following
exocrine pancreatic injury in vivo. STC2
Tg mice exhibit
a decreased proportional increase in serum amylase
levels, increased maintenance of cellular junctions,
decreased apoptosis and necrosis and decreased activa-
tion of CPA in exocrine pancreatic tissue, all suggestive
of decreased pancreatitis severity. In addition, the
enhanced autophagy observed in STC2
Tg acinar tissue
would facilitate more rapid degradation of resident
digestive enzymes upon injury, thereby limiting damage
to cellular contents. This would account for increased
maintenance of cellular junctions. However, to truly
understand the role of STC2 in pancreatic injury,
further experiments in mice lacking Stc2 mice should be
performed.
Conclusions
In conclusion, this is the first study to correlate PERK
signalling and STC2 in vivo,a n ds u g g e s t st w on o v e l
roles for STC2, as a downstream effector of PERK sig-
nalling and possible protective factor during pancreatic
injury. This is also the first time that STC2 has been
shown to affect proteins that regulate Ca
2+-mediated
response in the cell.
Methods
Mouse handling
For characterization of Stc2 expression during cerulein-
induced pancreatitis (CIP), wild type and Mist1
-/- mice
were maintained on a C57/Bl6 background. For analysis
of pancreatitis severity, STC2
Tg and wild type mice are
maintained on a C57/Bl6 × CBA background. Mice car-
rying a targeted ablation of the Mist1 gene (Mist1
-/-)
[39] and transgenic mice that express STC2 (STC2
Tg)
from the CMV promoter + chicken b-actin promoter
[22], have previously been described. All experiments
were approved by the Animal Care Committee at the
University of Western Ontario (Protocol #116-2008) and
mice handled according to regulations stipulated by the
Canadian Council on Animal Care.
Induction of pancreatitis
To induce pancreatic injury, 2-4 month-old female mice
were given up to seven hourly intraperitoneal injections
of cerulein (50 μg/kg body weight; Sigma-Aldrich). As a
control, mice were injected with 0.9% saline. Mice were
sacrificed 1, 4 or 8 hours after initial cerulein injection
and pancreatic tissue from each was immediately
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Figure 7 Schematic pathway showing a possible role for STC2
in affecting the PERK signalling pathway. The increased
accumulation of ATF4 leads to increased expression of GADD34,
ATF3 and STC2. Elevated levels of STC2 can alter both PERK
phosphorylation and ATF4 levels through as yet undetermined
mechanisms (dashed arrows), as well as promote reduced damage
during pancreatic injury. Whether this protective effect of STC2 is a
normal function of the protein needs to be clarified.
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Page 8 of 11processed to isolate RNA, protein, and tissue sections
for histological or immunohistochemical analysis. To
assess serum amylase, blood was obtained via cardiac
puncture, placed on ice for 20 minutes and centrifuged at
4°C, 2500 rpm for 15 minutes. Serum amylase was quanti-
fied using a Phadebas amylase assay (Magle Life Sciences,
Lund, Sweden) as per manufacturer’s instructions.
Tissue preparation and histology
Pancreatic tissue was either directly embedded in OCT
or incubated in formalin for 24 hours followed by paraf-
fin embedding. For morphological analysis, paraffin
embedded tissue was sectioned to 6 μM and stained
with hematoxylin and eosin. Immunofluorescent (IF)
analysis was performed on fresh frozen sections as
described previously [40]. Primary antibodies and their
dilutions are listed in Table 1. Following primary anti-
body incubation and PBS washes, sections were incu-
bated for 1 hour with the secondary antibodies of either
anti-rabbit FITC or anti-mouse TRITC (1:250; Sigma-
Aldrich). After further washing, sections were incubated
with 4’,6-diamidino-2-phenylindole (DAPI; 1:1000) and
slides were mounted with Vectashield (Vector Labora-
tories, Burlingame CA, USA). Histological staining was
visualized with a Leica DMIOS upright microscope and
images were captured using OpenLab 4.0.3 Software
(PerkinElmer, Waltham, MA, USA).
TUNEL analysis
TUNEL analysis was used to identify apoptotic cells
using the In situ Cell Death Detection kit (Roche, Laval,
QC, Canada) following manufacturer’s instructions.
Briefly, frozen sections were fixed, washed and permea-
bilized before labelling with TUNEL reaction mixture
for 60 minutes. After washing, sections were counter-
stained with DAPI, coverslipped and visualized using a
Leica DMIOS upright microscope and images were cap-
tured using OpenLab 4.0.3 Software (PerkinElmer, Wal-
tham, MA, USA). Analysis of percent apoptotic cells
was carried out by comparing TUNEL positive cells to
total cell number. Cell counts based on DAPI were
done using Image J software, and TUNEL positive cells
were determined manually. Ten random fields of view
from 4 sections per animal were used for analysis.
RNA isolation, Northern blotting and Real-Time RT-PCR
RNA was isolated from the splenic portion of the pancreas
and processed using TRIzol (Invitrogen, Burlington, ON,
Canada) as described [21]. Northern blotting was per-
formed as previously described [39]. Thirty μgo fR N A
was resolved by electrophoresis on a 1% agarose/formalde-
hyde gel and blotted onto Hybond membrane (GE Health-
care, Baie d’Urfe, QC, Canada). Membranes were
hybridized overnight at 42°C with an a-
32PdCTP radiola-
belled probe for Stc2 or for 18S rRNA as a loading control.
For RT-PCR, two μg of RNA was reverse transcribed
using Improm-II reverse transcriptase and random primers
( P r o m e g a ,M a d i s o nW I ,U S A ) .R T - P C Rf o rStc2, Atf3,
amylase and b-actin was performed with 1 μLo fc D N A
and Taq DNA polymerase (Promega, Madison WI, USA).
Protein isolation and immunoblot analysis
Protein extraction was carried out to obtain both
nuclear and cytoplasmic fractions. Briefly, 5 volumes of
Table 1 List of Primary Antibodies Used in Fazio et al (2011)
Antigen Species Company Dilution Method Reference
ATF3 Rabbit Santa Cruz Biotechnology (Santa Cruz, CA, USA) 1:1000 IB/IF Wu et al. (2010). Nature. 465: 368-372
ATF4 Rabbit Santa Cruz Biotechnology 1:500 IB Matsushita et al. (2009). Mol. Cell. Biol. 29: 5843-5857.
Calcineurin Mouse Sigma (St. Louis, MO, USA) 1:1000 IB
Calregulin Rabbit Santa Cruz Biotechnology 1:1000 IB
Pro-CPA Rabbit AbD Serotec (Oxford, UK) 1:2000 IB
b-catenin Mouse Transduction Laboratories (San Jose, CA, USA) 1:1000 IB/IF
Connexin 32 Mouse Millipore (Temecula, CA, USA) 1:1000 IB/IF
peIF2a Rabbit Invitrogen (Carlsbad, CA, USA) 1:1000 IB Harding et al. (2009). PNAS. 106(6), 1832-1837
total eIF2a Rabbit Cell Signalling (Beverly, MA, USA) 1:1000 IB Nanbo et al. (2002) EMBO J. 21, 954-965.
GADD34 Rabbit Santa Cruz Biotechnology 1:500 IB Makris et al. (2000). Mol. Cell. 5: 969-979.
GLUT2 Rabbit Millipore 1:1000 IB/IF
HMGB1 Rabbit Novus Biologicals (Littleton, CO, USA) 1:500 IF
LC3 Rabbit Novus Biologicals 1:1000 IB/IF
MIST1 Rabbit ProSci Incorporated (Poway, CA, USA) 1:500 IB/IF
PDX1 Rabbit Abcam (Cambridge, MA, USA) 1:1000 IB/IF
pPERK Rabbit Santa Cruz Biotechnology 1:500 IB/IF Denis et al. (2010). Neuroscience. 170(4):1035-44
Trypsin Rabbit Chemicon (Temecula, CA, USA) 1:2000 IB
1 - Abbreviations; IB, immunoblotting; IF, Immunofluorescence.
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Page 9 of 11buffer CE pH 7.6 (10 mm Hepes, 60 mM KCl, 1 mM
EDTA, 0.075% v/v NP-40, 1 mM DTT, 1 mM PMSF)
were added to whole pancreatic tissue prior to homoge-
nization. Homogenized cells were centrifuged at 1000
rpm, 4°C for 4 minutes. The supernatant was removed
and saved as cytoplasmic extract. The nuclear pellet was
gently washed with CE buffer lacking NP-40 and centri-
fuged again. After removal of the supernatant, the nuclear
pellet was covered with 1 pellet volume of NE buffer (20
mm Tris-HCl, 420 mM NaCl, 1.5 mm MgCl2,0 . 2m M
EDTA, 1 mM PMSF, 25% w/v glycerol) and the NaCl con-
centration was adjusted to 400 mM for the entire volume.
An additional pellet volume of NE buffer was added fol-
lowed by vortexing for resuspension. The extract was
incubated on ice for 10 minutes with intermittent vortex-
ing. Both cytoplasmic and nuclear extracts were centri-
fuged at 14,000 rpm, 4°C, for 10 minutes to pellet any
debris. Nuclear extracts were used for analysis of MIST1,
PDX1, XBP1 and ATF4 levels, whereas cytoplasmic
extracts were used for all other immunoblot analysis.
Electrophoresis and immunoblotting were carried out
as previously described [41]. For immunoblot analysis,
40 to 60 μg of pancreatic protein was resolved by SDS/
PAGE and transferred to PVDF membrane (Biorad, Mis-
sissauga, ON, Canada). Blots were blocked with 5% non-
fat dry milk (NFDM) and probed with primary antibo-
dies diluted in 5% NFDM overnight at 4°C. For primary
antibodies and their dilutions, see Table 1. Blots were
washed three times in PBS supplemented with Tween-
20 (PBS-T) then incubated with anti-rabbit or anti-
mouse horseradish peroxidase conjugated secondary
antibody (1:10,000 or 1:2000, Jackson Labs, Bar Harbor,
ME, USA) in 5% NFDM for one hour. Blots were sub-
jected to another series of washes in PBS-T, incubated
with Western Lightning chemiluminescence substrate
(Perkin Elmer, Waltham MA, USA), exposed to X-ray
film (Fisher Scientific, Ottawa, ON, Canada) and devel-
oped. Denistometry was performed on immunoblot
autoradiographs by analysis with a FluorChem 8800
documentation system and accompanying FluorChem
8800 software (Alpha Innotech, San Leandro CA, USA).
Statistical Analyses
All statistical analyses were performed using Graphpad
Prism 4.02 (Graphpad Software, San Diego CA, USA).
Carboxypeptidase cleavage and serum amylase levels
were analyzed using a two-way ANOVA followed by a
Bonferroni post-hoc test. Levels of phosphorylated
eIF2a and LC3 cleavage were statistically analyzed using
a Mann-Whitney test.
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